TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Lifeway Foods ( (LWAY) ) has provided an announcement.
On October 29, 2025, Lifeway Foods, Inc. announced an extension of its Shareholder Rights Agreement by one year, now expiring on October 29, 2026. The decision was made to protect against potential acquisition of control by shareholders without paying a premium, given the company’s concentrated share ownership and the potential for a substantial number of shares to become available for sale. This move aims to ensure that all shareholders can realize the full value of their investment and safeguard against control tactics without fair compensation.
The most recent analyst rating on (LWAY) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Lifeway Foods stock, see the LWAY Stock Forecast page.
Spark’s Take on LWAY Stock
According to Spark, TipRanks’ AI Analyst, LWAY is a Neutral.
Lifeway Foods’ overall stock score is primarily influenced by its strong financial performance, particularly in revenue growth and balance sheet strength. However, significant weaknesses in cash flow management and bearish technical indicators weigh heavily on the score. The high P/E ratio suggests potential overvaluation, further impacting the stock’s attractiveness.
To see Spark’s full report on LWAY stock, click here.
More about Lifeway Foods
Lifeway Foods, Inc. is a leading U.S. supplier of kefir and fermented probiotic products that support the microbiome. The company also produces a variety of cheeses and a ProBugs® line for kids. Its products are sold across the United States, Mexico, Ireland, South Africa, United Arab Emirates, and France.
Average Trading Volume: 124,816
Technical Sentiment Signal: Buy
Current Market Cap: $367.9M
Learn more about LWAY stock on TipRanks’ Stock Analysis page.